The recording of adverse events from psychological treatments in clinical trials: evidence from a review of NIHR-funded trials

被引:114
|
作者
Duggan, Conor [1 ,2 ]
Parry, Glenys [3 ]
McMurran, Mary [1 ]
Davidson, Kate [4 ]
Dennis, Jane [5 ]
机构
[1] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2TU, England
[2] Head Res & Dev, Borehamwood WD6 JN, Herts, England
[3] Univ Sheffield, Sch Hlth & Related Res, Ctr Psychol Serv Res, Sheffield S1 4DA, S Yorkshire, England
[4] Univ Glasgow, Gartnavel Royal Hosp, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland
[5] Social Well Fare Grp, Bristol BS6 7DB, Avon, England
来源
TRIALS | 2014年 / 15卷
基金
美国国家卫生研究院;
关键词
Harm; Adverse events; Psychological interventions; Clinical trials; RANDOMIZED-TRIALS; PSYCHOTHERAPY; EXTENSION; THERAPY; SAFETY; HARMS;
D O I
10.1186/1745-6215-15-335
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: There is a concern in the literature that harm from interventions is insufficiently documented in clinical trials in general, and in those assessing psychological treatments in particular. A recent decision by a trial steering committee to stop recruitment into a randomized controlled trial (RCT) of a psychological intervention for personality disorder led to an investigation of the recording of harm in trials funded by the National Institute for Health Research (NIHR). Methods: The protocols and final reports of all 82 NIHR trials funded between 1995 and 2013 were examined for the reporting of adverse events. These were subdivided by category of intervention. Results: None of the psychological intervention trials mentioned the occurrence of an adverse event in their final report. Trials of drug treatments were more likely to mention adverse events in their protocols compared with those using psychological treatments. When adverse events were mentioned, the protocols of psychological interventions relied heavily on severe adverse events guidelines from the National Research Ethics Service (NRES), which were developed for drug rather than psychological interventions and so may not be appropriate for the latter. Conclusions: This survey supported the belief that the reporting of adverse events in psychological treatments is weak and the criteria used may not be appropriate. Recommendations are made as to how current practice might be improved.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] COMBINING EVIDENCE FROM CLINICAL-TRIALS
    DERSIMONIAN, R
    ANESTHESIA AND ANALGESIA, 1990, 70 (05): : 475 - 476
  • [32] Pharmacotherapy of urolithiasis: evidence from clinical trials
    Moe, Orson W.
    Pearle, Margaret S.
    Sakhaee, Khashayar
    KIDNEY INTERNATIONAL, 2011, 79 (04) : 385 - 392
  • [33] Treating hypertension: The evidence from clinical trials
    Simon, JA
    BRITISH MEDICAL JOURNAL, 1996, 313 (7055): : 437 - 438
  • [34] Best practice: evidence from the clinical trials
    Cowie, MR
    HEART, 2002, 88 : 2 - 3
  • [35] Interpreting the evidence from tolvaptan clinical trials
    Tanaka, Toshikazu
    Kawana, Masataka
    Kohsaka, Shun
    JOURNAL OF CARDIOLOGY, 2019, 74 (02) : 195 - 195
  • [36] Serious adverse events and compensation in registration trials: A review of data from a Japanese university hospital
    Watanabe M.
    Tajima S.
    Katashima R.
    Miyamoto T.
    Yamagami M.
    Minakuchi K.
    Yanagawa H.
    BMC Research Notes, 7 (1)
  • [37] Lenalidomide: an update on evidence from clinical trials
    Dimopoulos, Meletios-Athanassios
    Terpos, Evangelos
    BLOOD REVIEWS, 2010, 24 : S21 - S26
  • [38] Treatments for metastatic melanoma: Synthesis of evidence from randomized trials
    Einarson, T. R.
    Lui, P.
    Cashin, R.
    Machado, M.
    Corey-Lisle, P.
    Hemels, M.
    VALUE IN HEALTH, 2006, 9 (06) : A202 - A203
  • [39] Antiplatelet treatments: recent evidence from randomized controlled trials
    Vogel, Birgit
    Baber, Usman
    CURRENT OPINION IN CARDIOLOGY, 2017, 32 (04) : 356 - 362
  • [40] Treatments for metastatic melanoma: Synthesis of evidence from randomized trials
    Lui, Philip
    Cashin, Richard
    Machado, Marcio
    Hemels, Michiel
    Corey-Lisle, Patricia K.
    Einarson, Thomas R.
    CANCER TREATMENT REVIEWS, 2007, 33 (08) : 665 - 680